Even without the IMOD contract, however, sales growth is undoubtedly accelerating (FY20 revenue was $46 million), gross margins are expanding and the company has won some smaller contracts on the side. These are great results and confirms the upwards growth trajectory over the last few years.
- Forums
- ASX - By Stock
- AVA
- AVA fundamental valuation
AVA fundamental valuation, page-13
Featured News
Add AVA (ASX) to my watchlist
|
|||||
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $30.39M |
Open | High | Low | Value | Volume |
11.0¢ | 11.0¢ | 10.5¢ | $9.635K | 89.68K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 294113 | 10.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
11.0¢ | 81015 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 294113 | 0.105 |
16 | 377990 | 0.100 |
1 | 30000 | 0.097 |
2 | 114582 | 0.096 |
3 | 107078 | 0.095 |
Price($) | Vol. | No. |
---|---|---|
0.110 | 81015 | 5 |
0.120 | 66853 | 5 |
0.125 | 46739 | 2 |
0.130 | 220522 | 6 |
0.135 | 309001 | 5 |
Last trade - 16.10pm 03/07/2024 (20 minute delay) ? |
Featured News
AVA (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO & MD
Anthony Noble
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online